MTS Transaction Experience

$73 million

Restructuring

Diagnostic Laboratory

2010

$17 million

Private Placement

Healthcare Information Technology

2010

$23 million

PIPE

Biotechnology

2009

$35 million

PIPE

Biotechnology

2009

$11 - 27 million

Sale

Biotechnology

2009

$37 million

Divestiture

Managed Care

2009

$213 million

Refinancing / Public Exchange Offer

Specialty Pharmaceuticals

2008

$15 million

PIPE

Biotechnology

2008

$40 million

Private Placement

Biotechnology

2008

$30 million

Private Placement

Biotechnology

2008

$18 million

PIPE

Biotechnology

2008

NA

Sale

Outsourcing/Other Services

2008

$350 million

Sale

Providers - Alternate Site

2007

$625 million

Acquisition

Providers - Long Term/Post Acute Care

2007

$630 million

Acquisition

Managed Care

2007

$125 million

Acquisition

Managed Care

2007

NA

Divestiture

Providers - Alternate Site

2007

$19 million

Sale

Providers - Long Term/Post Acute Care

2006

$240 million

Acquisition

Managed Care

2006

NA

Divestiture

Providers - Alternate Site

2006

$8.97 billion

Sale

Managed Care

2005

NA

Sale

Managed Care

2005

$246 million

Acquisition

Providers - Long Term/Post Acute Care

2005

NA

Acquisition

Managed Care

2005

$135 million

Restructuring

Providers - Alternate Site

2004

NA

Divestiture

Providers - Alternate Site

2004

$532 million

Acquisition

Managed Care

2004

$45 million

Sale

Managed Care

2004

$1.438 billion

Restructuring

Providers - Long Term/Post Acute Care

2004

$200 million

Structured Financing

Managed Care

2004

$150 million

Divestiture

Managed Care

2003

$75 million

PIPE

Providers - Long Term/Post Acute Care

2003

$90 million

Sale

Providers - Long Term/Post Acute Care

2003

$200 million

Financing

Managed Care

2002

$126 million

Debt Acquisition

Providers - Alternate Site

2001

$250 million

Debt Financing

Managed Care

2001

$1.4 billion

Sale

Pharmaceuticals - Generic

2000